|
Contents
|
 
|
|
|
|
|
|
|
Astrocytomas
|
|
|
|
Hanzely
Z, Polgar C, Fodor J, Brucher JM, Vitanovics D, Mangel LC, Afra D
Role
of early radiotherapy in the treatment of supratentorial WHO Grade II
astrocytomas: long-term results of 97 patients
J Neurooncol. 2003 Jul;63(3):305-12
|
|
T. E. Merchant, E. N. Kiehna,
R. K. Mulhern, L. E. Kun, S. Wu, X. Xiong, T. Williams, A. Gajjar, F. A.
Boop, R. A. Sanford
Results from a phase II trial of conformal
radiation therapy for pediatric patients with localized low-grade
astrocytoma and quantification of radiation-related CNS effects
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8533
|
|
Christian
Plathow M.D., Daniela Schulz-Ertner M.D., Christoph Thilman M.D., Ivan
Zuna Ph.D., Mathias Lichy M.D., Marc-André Weber M.D., Heinz-Peter
Schlemmer M.D., Michael Wannenmacher M.D. and Jürgen Debus M.D., Ph.D.
Fractionated
stereotactic radiotherapy in low-grade astrocytomas: Long-term outcome and
prognostic factors
Int J Radiat Oncol Biol Phys., Volume 57, Issue 4, 15 November 2003,
Pages 996-1003
|
|
Pilocytic Astrocytoma
|
|
|
Koji Tsuboi, Wakoto Matsuda, Kazuhiro Nakamura,
Shingo Takano, Akira Matsumura
Excision of Juvenile Pilocytic Astrocytoma of the
Midbrain after Radiotherapy
Pediatr Neurosurg. 2006 Aug;42(5):311-5
Abstract
|
|
|
Brain
Tumors
|
|
|
|
|
Das IJ, Cheng CW, Chopra KL, Mitra RK,
Srivastava SP, Glatstein E.
Intensity-modulated radiation therapy dose prescription, recording, and
delivery: patterns of variability among institutions and treatment planning
systems
J
Natl Cancer Inst. 2008 Mar 5;100(5):300-7.
Epub 2008 Feb 26
Abstract |
 Full Text |
 Reprint |
Supplemental
Data |
DBLinks | BL 7:7
|
|
McKernan
B, Bydder S, Deans T, Nixon M, Joseph Dj.
Surface laser scanning to routinely produce casts for
patient immobilization during radiotherapy.
Australas Radiol.
2007 Apr;51(2):150-3.
PMID: 17419860 [PubMed - in process]
|
|
Monje
ML, Palmer T
Radiation
injury and neurogenesis
Curr
Opin Neurol. 2003 Apr;16(2):129-34
|
|
Qin DX,
Zheng R, Tang J, Li JX, Hu YH
Influence
of radiation on the blood-brain barrier and optimum time of chemotherapy
Int J Radiat Oncol Biol Phys. 1990 Dec; 19(6): 1507-10
|
|
|
Yuan
J, Wang JZ, Lo S, Grecula JC, Ammirati M, Montebello JF, Zhang H, Gupta N,
Yuh WT, Mayr NA
Hypofractionation Regimens for Stereotactic Radiotherapy for Large Brain
Tumors
Int
J Radiat Oncol Biol Phys. 2008 Mar 27; [Epub ahead of print]
Abstract |
DBLinks | BL 7:8
|
|
|
Ependymal Tumors
|
|
|
|
Gilhuis
HJ, Kappelle AC, Beute G, Wesseling P, Grotenhuis A, Boerman RH
Radiotherapy
for partially resected spinal ependymomas: a retrospective study of 60 cases
Oncol
Rep. 2003 Nov-Dec;10(6):2079-82
|
|
Thomas E. Merchant, Raymond K. Mulhern, Matthew
J. Krasin, Larry E. Kun, Tani Williams, Chenghong
Li, Xiaoping Xiong, Raja B. Khan, Robert
H. Lustig, Frederick A. Boop, Robert A. Sanford
Preliminary Results From a Phase II Trial of Conformal Radiation Therapy and
Evaluation of Radiation-Related CNS Effects for Pediatric Patients With
Localized Ependymoma
Journal of Clinical Oncology,
Vol 22, No 15 (August 1), 2004: pp. 3156-3162
|
|
Reni M, Brandes AA, Vavassori V, Cavallo G, Casagrande
F, Vastola F, Magli A, Franzin A, Basso U, Villa E
A multicenter study of the prognosis
and treatment of adult brain ependymal tumors
Cancer. 2004 Mar 15;100(6):1221-9
|
|
|
Ganglioglioma
|
|
|
|
Zorlu F, Selek U, Onal C, Soylemezoglu F, Gurkaynak
M.
Postoperative radiotherapy in cranial
ganglioglioma.
J
Neurooncol. 2006 May;77(3):321-4. Epub
2005 Nov 29.
Abstract
|
|
|
Glioblastoma
|
|
|
|
Aoki T, Takahashi JA, Ueba T, Oya N, Hiraoka M, Matsui K,
Fukui T, Nakashima Y, Ishikawa M, Hashimoto
N.
Phase II study of nimustine, carboplatin,
vincristine, and interferon-beta with radiotherapy for glioblastoma multiforme:
experience of the Kyoto Neuro-Oncology Group.
J Neurosurg.
2006 Sep;105(3):385-91.
Abstract
|
|
Barker
FG 2nd, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, Malec MK,
McDermott MW, Sneed PK, Wara WM, Wilson CB.
Radiation
response and survival time in patients with glioblastoma multiforme
J Neurosurg 1996
Mar;84(3):442-8
|
|
R. Cardinale, M. Won,
A. Choucair, M. Gillin, A. Chakravarti,
C. Schultz, L. Souhami, A. Chen, H.
Pham and M. Mehta
A phase II trial of accelerated radiotherapy using weekly stereotactic
conformal boosts for supratentorial glioblastoma multiforme. RTOG-0023
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1511
Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005:
1511
|
|
Marc C. Chamberlain and Lisa Chalmers
A pilot study of primary temozolomide chemotherapy and deferred radiotherapy
in elderly patients with glioblastoma
J Neurooncol. 2006 Oct 4; [Epub
ahead of print]
Abstract
|
|
C. F. Classen, M. Warmuth-Metz, K. Papke,
A. Trotter, J. E. A. Wolff, S. Wagner
Late
response to radiochemotherapy in pediatric glioblastoma: report on two
patients treated according to HIT-GBM protocols
Pediatr
Hematol Oncol. 2006
Dec;23(8):631-7. DOI: 10.1080/08880010600951088
|
|
Herrlinger U, Rieger J, Koch D, Loeser S, Blaschke
B, Kortmann RD, Steinbach JP, Hundsberger T, Wick W, Meyermann R, Tan TC, Sommer
C, Bamberg M, Reifenberger G, Weller M.
Phase II trial of lomustine plus temozolomide chemotherapy in addition to
radiotherapy in newly diagnosed glioblastoma: UKT-03.
J Clin Oncol. 2006 Sep 20;24(27):4412-7.
Abstract
|
|
Hochberg FH,
Pruitt A
Assumptions
in the radiotherapy of glioblastoma
Neurology. 1980 Sep; 30(9): 907-11
|
|
K. A. Jaeckle, K. V.
Ballman, P. Schomberg, J. Uhm, B.
Schiethauer, C. Giannini, S. Felton, P.
Brown, B. C. Jan NCCTG
N997D: Pilot trial of CPT11 during RT followed by CPT11 and BCNU in newly
diagnosed glioblastoma (GBM) patients: A North Central Cancer Group (NCCTG)
study
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1514
Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005:
1514
|
|
S. Krishnan, P.
Brown, K. Ballman, J. Fiveash, J.
Uhm, C. Giannini, F. Geoffroy, L.
Nabors and J. Buckner
Phase I trial of erlotinib with
radiation therapy (RT) in patients with glioblastoma multiforme (GBM)
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1513
Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005:
1513
|
|
|
René-Olivier Mirimanoff, Thierry
Gorlia, Warren Mason, Martin J. Van den Bent,
Rolf-Dieter Kortmann, Barbara Fisher, Michele
Reni, Alba A. Brandes, Jüergen Curschmann,
Salvador Villa, Gregory Cairncross, Anouk
Allgeier, Denis Lacombe, Roger Stupp
Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive
Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized
Trial
J
Clin Oncol. 2006 Jun 1;24(16):2563-9. DOI: 10.1200/JCO.2005.04.5963
Abstract
|
|
|
Piroth MD, Gagel B, Pinkawa M, Stanzel S,
Asadpour B, Eble MJ
Postoperative Radiotherapy of Glioblastoma Multiforme : Analysis and
Critical Assessment of Different Treatment Strategies and Predictive Factors
Strahlenther
Onkol. 2007 Dec;183(12):695-702.
Epub 2007 Nov 27
Abstract |
DBLinks
|
|
W.
Roa, P.M.A. Brasher, G. Bauman, M.
Anthes, E. Bruera, A. Chan, B.
Fisher, D. Fulton, S. Gulavita, C.
Hao, S. Husain, A. Murtha, K.
Petruk, D. Stewart, P. Tai, R.
Urtasun, J.G. Cairncross, P. Forsyth
Abbreviated
Course of Radiation Therapy in Older Patients With Glioblastoma
Multiforme: A Prospective Randomized Clinical Trial
Journal of Clinical
Oncology, Vol 22, No 9 (May 1), 2004: pp. 1583-1588. (Abstract+)
|
|
|
H. Ian Robins, M. Won,
Wendy F. Seiferheld, Christopher J. Schultz, Ali
K. Choucair, David G. Brachman, William F. Demas
and Minesh P. Mehta
Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma
multiforme: RTOG protocol BR-0021
Abstract
|
|
Saito T, Hama S, Kajiwara Y, Sugiyama K, Yamasaki F,
Arifin MT, Arita K, Kurisu K.
Prognosis of cerebellar glioblastomas: correlation between prognosis and
immunoreactivity for epidermal growth factor receptor compared with
supratentorial glioblastomas.
Anticancer Res. 2006
Mar-Apr;26(2B):1351-7.
Abstract
|
|
J.-M. Simon, K.
Mokhtari, C. Genestie, A. Bissery,
J.-J. Mazeron and P. Jaillon
Hypoxia-inducible factor 1alpha (HIF-1α) and carbonic
anhydrase IX (CA 9) expressions in glioblastoma multiform to
predict response to radiation therapy
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1512
Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005:
1512
|
|
Roger Stupp, M.D., Warren
P. Mason, M.D., Martin J. van den Bent, M.D., Michael Weller, M.D.,
Barbara Fisher, M.D., Martin J.B. Taphoorn, M.D., Karl Belanger, M.D.,
Alba A. Brandes, M.D., Christine Marosi, M.D., Ulrich Bogdahn, M.D.,
Jürgen Curschmann, M.D., Robert C. Janzer, M.D., Samuel K. Ludwin,
M.D., Thierry Gorlia, M.Sc., Anouk Allgeier, Ph.D., Denis Lacombe, M.D.,
J. Gregory Cairncross, M.D., Elizabeth Eisenhauer, M.D., René O.
Mirimanoff, M.D., for the European Organisation for Research and
Treatment of Cancer Brain Tumor and Radiotherapy Groups and the National
Cancer Institute of Canada Clinical Trials Group
Radiotherapy plus Concomitant
and Adjuvant Temozolomide for Glioblastoma
The New England Journal of Medicine, Volume
352:987-996, Number 10, March 10, 2005
Abstract
| BrainLife |
Full
Text |
Reprint
|
|
Sultanem
K, Patrocinio H, Lambert C, Corns R, Leblanc R, Parker W, Shenouda G,
Souhami L
The use
of hypofractionated intensity-modulated irradiation in the treatment of
glioblastoma multiforme: preliminary results of a prospective trial
Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):247-52
|
|
Christopher D. Turner, Susan Chi,
Karen J. Marcus, Tobey MacDonald, Roger J. Packer, Tina Young Poussaint,
Sridhar Vajapeyam, Nicole Ullrich, Liliana C. Goumnerova, R. Michael Scott,
Caitlin Briody, Christine Chordas, Mary Ann Zimmerman and
Mark W. Kieran
Phase II study of thalidomide and radiation in children with newly diagnosed
brain stem gliomas and glioblastoma multiforme
J Neurooncol. 2006 Sep 22; [Epub
ahead of print]
Abstract
|
|
Yao
KC, Komata T, Kondo Y, Kanzawa T, Kondo S, Germano IM
Molecular
response of human glioblastoma multiforme cells to ionizing radiation:
cell cycle arrest, modulation of the expression of cyclin-dependent kinase
inhibitors, and autophagy
J Neurosurg 2003 Feb;98(2):378-84
|
|
|
[No authors listed]
[Intraoperative radiotherapy by means of a photon radiosurgical system
(PRS400) after removal of recurring glioblastoma]
Zh Vopr Neirokhir Im N N Burdenko. 2007 Jul-Sep;(3):39-40. Russian - PMID:
18041212
Abstract |
DBLinks
|
|
|
Gliomas
|
|
|
|
A.
L. Grosu, W. A. Weber, R. Lachner, N. Wiedemann, C. Nieder, E. Mergen,
M. Schwaiger, M. Molls
C11-methionine
PET in radiotherapy planning of glioma
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
428
|
|
A.
E. Sloan, S. Lo, K. Levin, A. Frazier, L. Gaspar, Karmanos Cancer Institute,
Wayne State
Outcome of radiation therapy for intramedullary spinal
cord glioma-Wayne State University experience
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003.
Abstract No. 449
|
|
Smith
JS, Parney IF, Lamborn KR, McDermott MW, Sneed PK, Chang SM.
Treatment for posterior fossa
dissemination of primary supratentorial glioma.
J Neurosurg. 2007
Apr;106(4):567-74.
PMID: 17432705 [PubMed - in process]
|
|
|
Gliomas
(High-Grade)
|
|
|
|
Giuseppe Luigi Banna, Daniela Bettio,
Marta Scorsetti, Pierina Navarria, Matteo Simonelli, Riccardo Rodriguez
Baena, Enrico Aimar, Paolo Gaetani, PierGiuseppe Colombo, Felice Rognone
and Armando Santoro
Administration of temozolomide during and after radiotherapy for newly
diagnosed high-grade gliomas excluding glioblastoma multiforme
J Neurooncol. 2006 Sep 23; [Epub
ahead of print]
Abstract
|
|
Corn BW, Yousem DM, Scott CB, Rotman M, Asbell SO, Nelson DF,
Martin L, Curran WJ Jr
White
matter changes are correlated significantly with radiation dose.
Observations from a randomized dose-escalation trial for malignant glioma
(Radiation Therapy Oncology Group 83-02)
Cancer. 1994 Nov
15;74(10):2828-35
|
|
|
Antje Ernst-Stecken, Oliver Ganslandt,
Ulrike Lambrecht, Rolf Sauer and Gerhard Grabenbauer
Survival and quality of life after hypofractionated stereotactic
radiotherapy for recurrent malignant glioma
J Neurooncol. 2006 Sep 20; [Epub
ahead of print]
Abstract
|
|
Anna Gregor, Ann Cull
Radiotherapy for malignant glioma
BMJ
313:1500-1501.14 December 1996. (HTML Full Text)
|
|
Kaneko
S, Abe H, Aida T, Tokuda K, Tsuru M, Kitaoka K, Sato M, Iwakuma T, Ueno K,
Kashiwaba T
Evaluation of radiation immunochemotherapy in the
treatment of malignant glioma. Combined use of ACNU, VCR and PS-K
Hokkaido Igaku Zasshi 1983 Nov;58(6):622-30
|
|
A. Narayana, J. Yamada, M.
Hunt, P. Shah, P. Gutin, S. A. Leibel
Intensity modulated radiotherapy in high grade
gliomas: Clinical and dosimetric results
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1532
|
|
Pinel
S, Chastagner
P, Merlin
JL, Marchal
C, Taghian
A, Barberi-Heyob
M
Topotecan can compensate for protracted radiation
treatment time effects in high grade glioma xenografts (bigstar)
J
Neurooncol. 2005 Nov 16; [Epub ahead of print]
|
|
Rubino G, Sacco P, Cerase A, Volterrani L, Sebaste L,
Pepi F, Pirtoli L
Radiotherapy of malignant gliomas: results from
conventional treatment methods and the prospects of advanced techniques
Radiol Med (Torino). 2004 Jan-Feb;107(1-2):128-35. (PDF Full Text)
|
|
Sharma RR, Singh DP, Pathak A, Khandelwal N, Sehgal
CM, Kapoor R, Ghoshal S, Patel FD, Sharma SC
Local control of high-grade gliomas with limited
volume irradiation versus whole brain irradiation
Neurol India. 2003 Dec;51(4):512-7. (PDF Full
Text)
|
|
Shepherd SF,
Laing RW, Cosgrove VP, Warrington AP, Hines F, Ashley SE, Brada M
Hypofractionated
stereotactic radiotherapy in the management of recurrent glioma
Int J Radiat Oncol Biol Phys. 1997 Jan 15; 37(2): 393-8
|
|
Walker
MD, Strike TA, Sheline GE
An
analysis of dose-effect relationship in the radiotherapy of malignant
gliomas
Int J Radiat Oncol Biol Phys. 1979 Oct; 5(10): 1725-31
|
|
|
Gliomas
(Low-Grade)
|
|
|
|
|
Ehsani S, Hodaie M, Liebsch NJ, Gentili F, Kiehl
TR.
Anaplastic glioma after high-dose proton-photon radiation treatment for
low-grade skull base chondrosarcoma
J Neurooncol.
2008 Mar 15; [Epub ahead of print]
Abstract |
DBLinks | BL 7:7
|
|
Glenn Bauman, Peter Pahapill, David
Macdonald, Barbara Fisher, Christopher Leighton, Gregory Cairncross
Low Grade Glioma: A Measuring
Radiographic Response to Radiotherapy
The Canadian J of Neurological Sciences, Volume 26, Number 1, Pages 18-22 /
February 1999. (PDF Full Text)
|
|
Paul Brown,
Jan Buckner
In Reply:
Journal of Clinical Oncology, Vol 22, No 5 (March 1), 2004: pp. 967-968. (Reference+)
|
|
Paul
D. Brown, Jan C. Buckner, Judith R.
O’Fallon, Nancy L. Iturria, Cerise A. Brown,
Brian P. O’Neill, Bernd W. Scheithauer, Robert
P. Dinapoli, Robert M. Arusell, Walter J. Curran,
Ross Abrams, Edward G. Shaw
Effects of Radiotherapy on
Cognitive Function in Patients With Low-Grade Glioma Measured by the
Folstein Mini-Mental State Examination
Journal of Clinical Oncology, Vol 21, Issue 13 (July), 2003: 2519-2524. (Abstract+)
|
|
Karim
AB, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, Darcel F, Stenning S,
Pierart M, Van Glabbeke M
Randomized
trial on the efficacy of radiotherapy for cerebral low-grade glioma in the
adult: European Organization for Research and Treatment of Cancer Study 22845
with the Medical Research Council study BRO4: an interim analysis
Int
J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):316-24
|
|
Karim
AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, Mascarenhas F,
Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini MG, van Alphen AM, Hamers
HP, Gaspar L, Noordman E, Pierart M, van Glabbeke M
A randomized trial on dose-response
in radiation therapy of low-grade cerebral glioma: European Organization for
Research and Treatment of Cancer (EORTC) Study 22844
Int
J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):549-56
|
|
Kiebert
GM, Curran D, Aaronson NK, Bolla M, Menten J, Rutten EH, Nordman E,
Silvestre ME, Pierart M, Karim AB
Quality
of life after radiation therapy of cerebral low-grade gliomas of the adult:
results of a randomised phase III trial on dose response (EORTC trial 22844).
EORTC Radiotherapy Co-operative Group
Eur
J Cancer. 1998
Nov;34(12):1902-9
|
|
Martin Klein,
Jan J. Heimans
The Measurement of Cognitive
Functioning in Low-Grade Glioma Patients After Radiotherapy
Journal of Clinical Oncology, Vol 22, No 5 (March 1), 2004: pp. 966-967.
(Reference+)
|
|
Christina A. Meyers,
Jeffrey S. Wefel
The Use of the Mini-Mental State
Examination to Assess Cognitive Functioning in Cancer Trials: No Ifs,
Ands, Buts, or Sensitivity
J Clin Oncol, Vol 21, Issue 19 (Oct.), 2003: 3557-3558.
Originally published as JCO Early Release on Aug. 11 2003. (Reference+)
|
|
Francesco Pignatti, Martin
van den Bent, Desmond Curran, Channa
Debruyne, Richard Sylvester, Patrick
Therasse, Denes Áfra, Philippe Cornu,
Michel Bolla, Charles Vecht, Abul
B.M.F. Karim for the European Organization for Research and
Treatment of Cancer Brain Tumor Cooperative Group and Radiotherapy
Cooperative Group
Prognostic Factors for Survival in
Adult Patients With Cerebral Low-Grade Glioma
Journal of Clinical Oncology, Vol 20,
Issue 8 (April), 2002: 2076-2084. (Abstract+)
|
|
Ribom
D, Engler H, Blomquist E, Smits A
Potential
significance of (11)C-methionine PET as a marker for the radiosensitivity of
low-grade gliomas
Eur
J Nucl Med Mol Imaging. 2002 May;29(5):632-40. Epub 2002 Mar 5
|
|
Koh-ichi Sakata, Masato
Hareyama, Takashi Komae, Hiroki Shirato, Osamu
Watanabe, Jiroh Watarai, Kenji Takai, Shogo
Yamada, Emiko Tsuchida and Kunio Sakai
Supratentorial Astrocytomas and
Oligodendrogliomas Treated in the MRI Era
Japanese Journal of Clinical Oncology, June 2001, 31:240-245. (PDF Full Text)
|
|
|
Melanocytoma
|
|
|
|
Rades D, Schild SE.
Dose-response relationship for fractionated
irradiation in the treatment of spinal meningeal melanocytomas: a review of the
literature.
J
Neurooncol. 2006 May;77(3):311-4. Epub
2005 Dec 3.
Abstract
|
|
|
Medulloblastoma
|
|
|
|
Dr, Prof Amar Gajjar
MD, Murali Chintagumpala MD,
David Ashley MBBS, Stewart Kellie
MBBS, Prof Larry E Kun MD, Prof
Thomas E Merchant DO, Shaio Woo
MD, Greg Wheeler MBBS, Valerie Ahern
MBBS, Matthew J Krasin MD, Maryam Fouladi
MD, Alberto Broniscer MD, Prof
Robert Krance MD, Gregory A Hale
MD, Clinton F Stewart PharmD,
Robert Dauser MD, Prof
Robert A Sanford MD, Christine Fuller
MD, Ching Lau MD, Prof
James M Boyett PhD, Dana Wallace
MS and Richard J Gilbertson MD
Risk-adapted
craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell
rescue in children with newly diagnosed medulloblastoma (St Jude
Medulloblastoma-96): long-term results from a prospective, multicentre
trial
Lancet Oncology Early
Online Publication, 7 September 2006,
DOI:10.1016/S1470-2045(06)70867-1
Abstract
/ 
Abstract |
News
/
News
|
|
Suzanne L. Wolden, Ira J. Dunkel, Mark
M. Souweidane, Laura Happersett, Yasmin Khakoo,
Karen Schupak, David Lyden, Steven A. Leibel
Patterns of Failure Using a Conformal Radiation Therapy Tumor Bed Boost for
Medulloblastoma
Journal of Clinical Oncology, Vol 21, Issue 16, August
15, 2003: 3079-3083. (Abstract+)
|
|
|
Meningioma
|
|
|
|
Simon
S Lo, Kwan H Cho, Walter A Hall, Wilson L Hernandez, Kimberly K McCollow,
Judy Unger
Is
stereotactic radiotherapy adequate treatment for atypical and malignant
meningiomas?
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. Abstract No.
293
|
|
Simon M, Bostrom J, Koch P, Schramm J
Inter-institutional variance of
postoperative radiotherapy and follow up for meningiomas in Germany. Impact of
changes of the WHO classification
J
Neurol Neurosurg Psychiatry. 2005 Nov 23; [Epub ahead of print]. (PDF Full Text)
|
|
|
Metastatic Tumors
|
|
|
|
Nada D Bajic, Danijela D
Scepanovic
Whole
brain irradiation doses and overall survival in patients with brain
metastases
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No.
2106
|
|
Berk
L, Berkey B, Rich T, Hrushesky W, Blask D, Gallagher M, Kudrimoti M,
McGarry RC, Suh J, Mehta M.
Randomized phase II trial of high-dose melatonin and
radiation therapy for rpa class 2 patients with brain metastases (RTOG
0119).
Int
J Radiat Oncol Biol Phys. 2007 Apr 5; [Epub ahead of print]
PMID: 17418968 [PubMed - as supplied by publisher]
|
|
Cannady
SB, Cavanaugh KA, Lee SY, Bukowski RM, Olencki TE, Stevens GH, Barnett
GH, Suh JH
Results
of whole brain radiotherapy and recursive partitioning analysis in
patients with brain metastases from renal cell carcinoma: a retrospective
study
Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):253-8
|
|
M. T. Carpenter, J. C. Flickinger,
M. A. Quader, C. E. Miles
Improvements in technique for whole-brain
irradiation
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1539
|
|
Chee
R, Bydder S, Cameron F.
Prolonged survival after resection and radiotherapy for
solitary brain metastases from non-small-cell lung cancer.
Australas Radiol.
2007 Apr;51(2):186-9.
PMID: 17419869 [PubMed - in process]
|
|
Datta R, Jawahar A, Ampil FL, Shi R, Nanda A, D'Agostino H
Survival in relation to radiotherapeutic modality for brain
metastasis: whole brain irradiation vs. gamma knife radiosurgery
Am J Clin Oncol. 2004 Aug;27(4):420-4
|
|
Fleckenstein K, Hof H, Lohr F, Wenz F, Wannenmacher M
Prognostic factors for brain metastases after
whole brain radiotherapy. Data from a single institution
Strahlenther Onkol. 2004 May;180(5):268-73
|
|
J.
P. Knisely, B. A. Berkey, A. Chakravarti, W. A. Yung, W. J. Curran, H.
I. Robins, B. Movsas, D. G. Brachman, R. H. Henderson, M. P. Mehta
RTOG 0118: A Phase III
Study of Conventional Radiation Therapy Alone vs. Conventional Radiation
Therapy Plus Thalidomide for Multiple Brain Metastases
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1500
Journal of Clinical Oncology,
Vol 23, No 16S (June 1 Supplement), 2005: 1500
|
|
|
Kouvaris
JR, Miliadou A, Kouloulias VE, Kolokouris D, Balafouta MJ, Papacharalampous
XN, Vlahos LJ.
Phase II Study of Temozolomide and Concomitant Whole-Brain Radiotherapy in
Patients with Brain Metastases from Solid Tumors.
Onkologie. 2007
Jul;30(7):361-6. Epub 2007 Jun 27.
PMID: 17596744 [PubMed - in process]
|
|
|
J. Li, S. M. Bentzen, M. Renschler, M. P. Mehta
Improvement in neurocognitive function (NCF) correlates with tumor
regression after whole brain radiation therapy (WBRT) for brain metastases
(BM)
Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings
Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 1504
Abstract
|
News
|
|
|
M. P. Mehta, R. Gervais, P. Chabot, W. R. Shapiro, R. A. Patchell, M.
J. Glantz, L. Recht, S. Phan, J. A. Smith, M. F. Renschler
Motexafin gadolinium (MGd) combined with prompt whole brain radiation
therapy (RT) prolongs time to neurologic progression in non-small cell lung
cancer (NSCLC) patients with brain metastases: Results of a phase III trial
Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings
Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 7014
Abstract
|
News
|
|
Christina A. Meyers, Jennifer
A. Smith, Andrea Bezjak, Minesh P. Mehta,
James Liebmann, Tim Illidge, Ian Kunkler,
Jean-Michel Caudrelier, Peter D. Eisenberg, Jacobus
Meerwaldt, Ross Siemers, Christian Carrie,
Laurie E. Gaspar, Walter Curran, See-Chun
Phan, Richard A. Miller, Markus F. Renschler
Neurocognitive Function and Progression
in Patients With Brain Metastases Treated With Whole-Brain Radiation and
Motexafin Gadolinium: Results of a Randomized Phase III Trial
J Clin Oncol, Vol 22, No 1 (January 1), 2004: pp. 157-165
(PDF Full Text)
|
|
|
Rades
D, Kieckebusch S, Haatanen T, Lohynska R, Dunst J, Schild SE
Surgical resection followed by whole brain radiotherapy versus whole brain
radiotherapy alone for single brain metastasis
Int
J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1319-24;
Epub 2008 Mar 25
Abstract |
DBLinks | BL 7:8
|
|
|
Sharma
V, Gaye PM, Wahab SA, Ndlovu N, Ngoma T, Vanderpuye V, Sowunmi A,
Kigula-Mugambe J, Jeremic B.
Patterns of Practice of Palliative Radiotherapy in
Africa, Part 1: Bone and Brain Metastases.
Int
J Radiat Oncol Biol Phys. 2007 Oct 29; [Epub ahead of print]
Abstract
|
|
R.
Soffietti, G. Beltramo, A. Costanza, E. Laguzzi, C. Mantovani, M. Nobile, R.
Ruda'
Fractionated
stereotactic radiotherapy for brain metastases from non small-cell lung cancer
39th ASCO Annual
Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
454
|
|
|
Weller
M.
Radiochemotherapy for brain metastasis: how to define a role for
temozolomide.
Onkologie. 2007
Jul;30(7):350-1. Epub 2007 Jun 27. No abstract available.
PMID: 17596741 [PubMed - in process]
|
|
|
Oligo.Tumors & Mixed Gliomas
|
|
|
|
|
Martin J. van den Bent, Antoine
F. Carpentier, Alba A. Brandes, Marc Sanson,
Martin J.B. Taphoorn, Hans J.J.A. Bernsen, Marc
Frenay, Cees C. Tijssen, Wolfgang Grisold, Laslo
Sipos, Hanny Haaxma-Reiche, Johannes M. Kros,
Mathilde C.M. van Kouwenhoven, Charles J. Vecht, Anouk
Allgeier, Denis Lacombe, Thierry Gorlia
Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free
Survival but Not Overall Survival in Newly Diagnosed Anaplastic
Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation
for Research and Treatment of Cancer Phase III Trial
Journal of Clinical Oncology, Vol 24, No 18 (June
20), 2006: pp. 2715-2722. DOI:
10.1200/JCO.2005.04.6078
|
|
M. J.
van den Bent, J. Delattre, A. A. Brandes, M. J. Taphoorn, K. Hoang
Xuan, H. Bernsen, M. Frenay, W. Grisold, T. Gorlia, D. Lacombe
First analysis of EORTC trial
26951, a randomized phase III study of adjuvant PCV chemotherapy in
patients with highly anaplastic oligodendroglioma
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1503
Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005:
1503
|
|
|
Gregory Cairncross, Brian
Berkey, Edward Shaw, Robert Jenkins, Bernd
Scheithauer, David Brachman, Jan Buckner, Karen
Fink, Luis Souhami, Normand Laperierre, Minesh
Mehta, Walter Curran
Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy
Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation
Therapy Oncology Group Trial 9402
Journal of Clinical Oncology, Vol 24, No 18 (June
20), 2006: pp. 2707-2714. DOI:
10.1200/JCO.2005.04.3414
|
|
|
Mark R. Gilbert, Frederick F.
Lang
Anaplastic Oligodendroglial Tumors: A Tale of Two Trials
Journal of Clinical Oncology, Vol 24, No 18 (June
20), 2006: pp. 2689-2690. DOI:
10.1200/JCO.2006.05.8594
|
|
|
Pediatric
CNS Tumors
|
|
|
|
Glenn
Bauman, Barbara Fisher, Elizabeth Cairney, Adriana Ranger, A. Rashid Dar, Jill
Ross, Larry Stitt, David Macdonald
Radiotherapy for Pediatric Central Nervous
System Tumors: A Regional Cancer Centre Experience
Journal of Neuro-Oncology, 68 (3): 285-294, July 2004. (Abstract+)
|
|
|
Primary
CNS Lymphoma
|
|
|
|
|
Illerhaus G, Marks R, Ihorst G, Guttenberger R,
Ostertag
C, Derigs G, Frickhofen N, Feuerhake F, Volk B, Finke J.
High-dose chemotherapy with autologous
stem-cell transplantation and hyperfractionated radiotherapy as first-line
treatment of primary CNS lymphoma.
J
Clin Oncol. 2006 Aug
20;24(24):3865-70. Epub 2006 Jul 24.
Abstract
|
|
Laack NN, Ballman KV, Brown PB, O'Neill BP; North
Central Cancer Treatment Group.
Whole-brain radiotherapy and high-dose methylprednisolone
for elderly patients with primary central nervous system lymphoma: Results of
North Central Cancer Treatment Group (NCCTG) 96-73-51.
Int
J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1429-39.
Abstract
|
bottom
|
